Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome

Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome

ABSTRACT The introduction of mutation-specific combination therapy with the cystic fibrosis transmembrane conductance regulator (CFTR) modulators elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) has substantially improved lung function and quality of life of people with cystic fibrosis (CF). Collectin...

Full description

Bibliographic Details
Main Authors: Sophia T. Pallenberg, Marie-Madlen Pust, Ilona Rosenboom, Gesine Hansen, Lutz Wiehlmann, Anna-Maria Dittrich, Burkhard Tümmler
Format: Article
Language:English
Published: American Society for Microbiology 2022-10-01
Series:Microbiology Spectrum
Subjects:
CFTR modulation
ELX/TEZ/IVA
airway metagenome
cystic fibrosis
metagenomics
whole-genome sequencing
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01454-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.01454-22

Similar Items